NPWA.F Smith & Nephew plc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
28.00 EUR
Close of Nov 13, 2026
23.00 30.35
Market cap
EUR 11.7B
P/E
22.2x
P/B
2.51x
ROE
11.8%
Dividend yield
2.49%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is NPWA.F undervalued?

Graham number
Price28.00
Graham value17.79
Premium57.4%

NPWA.F trades 57.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Smith & Nephew plc fundamental analysis

No fundamental analysis for Smith & Nephew plc yet.

Smith & Nephew plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used i…

Full company profile